首页> 外文期刊>Immunity >Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
【24h】

Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens

机译:前体频率和亲和力确定生发中心的B细胞竞争性健康,用种系靶向HIV疫苗免疫原进行测试

获取原文
获取原文并翻译 | 示例
           

摘要

How precursor frequencies and antigen affinities impact interclonal B cell competition is a particularly relevant issue for candidate germline-targeting HIV vaccine designs because of the in vivo rarity of naive B cells that recognize broadly neutralizing epitopes. Knowing the frequencies and affinities of HIV-specific VRC01-class naive human B cells, we transferred B cells with germline VRC01 B cell receptors into congenic recipients to elucidate the roles of precursor frequency, antigen affinity, and avidity on B cell responses following immunization. All three factors were interdependently limiting for competitive success of VRC01-class B cells. In physiological high-affinity conditions using a multivalent immunogen, rare VRC01-class B cells successfully competed in germinal centers (GC), underwent extensive somatic hypermutation, and differentiated into memory B cells. The data reveal dominant influences of precursor frequency, affinity, and avidity for interclonal GC competition and indicate that germline-targeting immunogens can overcome these challenges with high-affinity multimeric designs.
机译:前体频率和抗原亲和力如何影响间面的B细胞竞争是候选种系靶向艾滋病毒疫苗设计的一个特别相关的问题,因为识别广泛中和表位的幼稚B细胞的体内稀有性。了解HIV特异性VRCO1级幼稚人B细胞的频率和亲和力,我们将B细胞与种系VRCO1B细胞受体转移到CONCIC接受者中,以阐明前体频率,抗原亲和力和亲和力在免疫后B细胞应答的作用。所有三种因素都是相互依存的VRC01-B类细胞竞争成功的限制。在使用多价免疫原的生理高亲和力条件下,稀有的VRCO1-B类B细胞成功地竞争生发中心(GC),经历了广泛的体细胞高原,并分化为内存B细胞。该数据揭示了前体频率,亲和力和亲和力的主要影响因素GC竞争,表明种系靶向免疫原具有高亲和力多聚体设计克服这些挑战。

著录项

  • 来源
    《Immunity》 |2018年第1期|共19页
  • 作者单位

    La Jolla Inst Allergy &

    Immunol Div Vaccine Discovery La Jolla CA 92037 USA;

    La Jolla Inst Allergy &

    Immunol Div Vaccine Discovery La Jolla CA 92037 USA;

    Scripps Res Inst Ctr HIV AIDS Vaccine Immunol &

    Immunogen Discover La Jolla CA 92037 USA;

    Scripps Res Inst Dept Immunol &

    Microbiol La Jolla CA 92037 USA;

    La Jolla Inst Allergy &

    Immunol Div Vaccine Discovery La Jolla CA 92037 USA;

    Scripps Res Inst Dept Immunol &

    Microbiol La Jolla CA 92037 USA;

    Scripps Res Inst Ctr HIV AIDS Vaccine Immunol &

    Immunogen Discover La Jolla CA 92037 USA;

    Scripps Res Inst Dept Immunol &

    Microbiol La Jolla CA 92037 USA;

    Scripps Res Inst Ctr HIV AIDS Vaccine Immunol &

    Immunogen Discover La Jolla CA 92037 USA;

    La Jolla Inst Allergy &

    Immunol Div Vaccine Discovery La Jolla CA 92037 USA;

    Scripps Res Inst Ctr HIV AIDS Vaccine Immunol &

    Immunogen Discover La Jolla CA 92037 USA;

    Scripps Res Inst Dept Immunol &

    Microbiol La Jolla CA 92037 USA;

    La Jolla Inst Allergy &

    Immunol Div Vaccine Discovery La Jolla CA 92037 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学免疫学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号